Sonoma Pharmaceuticals, Inc. (SNOA)

↓ Download CSV

CIK 0001367083 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Mar 31

In fiscal 2026, Sonoma Pharmaceuticals, Inc. reported revenue of $19.53M, up 36.7% from the prior year. The company ran a net loss, with a net margin of -16.3% and a gross margin of 38.0%. It held $13.96M in total assets against $10.87M in total liabilities.

Key ratios (FY2026)

38.0%
Gross margin
-12.6%
Operating margin
-16.3%
Net margin
-102.6%
Return on equity
+36.7%
Revenue growth (YoY)
Metric (FY)2026202520242023202220212020201920182017
Revenue$19.53M$14.29M$12.73M$13.27M$12.63M$18.63M$18.97M$16.66M$12.82M
Cost of Revenue$12.11M$8.82M$10.09M$9.35M$7.16M
Gross Profit$7.42M$5.46M$4.75M$4.48M$3.99M$6.56M$8.12M$8.88M$7.31M$5.67M
Operating Income-$2.46M-$3.71M-$4.70M-$4.57M-$5.89M-$3.45M-$7.39M-$11.26M-$14.19M-$12.97M
Net Income-$3.17M-$3.46M-$4.83M-$5.15M-$5.09M-$3.95M-$3.31M-$11.80M-$14.33M$9.27M
EPS (Diluted)$-1.89$-2.79$-10.63$-1.52$-1.92
Total Assets$13.96M$13.69M$14.74M$16.23M$18.84M$14.99M$14.56M$14.45M$19.21M$25.46M
Total Liabilities$10.87M$9.28M$8.60M$8.25M$10.15M$9.62M$8.94M$3.96M$3.88M$4.03M
Shareholders' Equity$3.10M$4.41M$6.14M$7.98M$8.70M$5.36M$5.62M$7.77M$15.33M$21.43M
Cash & Equivalents$2.40M$5.37M$3.13M$3.82M$7.40M$4.22M$3.69M$3.69M$10.07M$17.46M
Operating Cash Flow-$3.93M-$88.0K-$2.40M-$6.15M-$4.25M-$3.38M-$4.59M-$11.72M
Capital Expenditures$192.0K$80.0K$2.0K$269.0K$137.0K$179.0K$206.0K$100.0K$187.0K$394.0K
Shares Outstanding1.80M1.63M1.06M4.93M3.10M2.09M1.78M1.33M685.7K4.29M